https://bio.nikkeibp.co.jp/atcl/news/p1/25/06/19/13435/
https://www.nature.com/articles/s41536-025-00411-4
A research team from Nagoya University and Keio University has succeeded in creating lung cells from mouse embryonic fibroblasts in a short period of time. The fibroblasts were directly reprogrammed and induced to become stem cells that are the source of lung cells. This could lead to the development of cell medicines derived from autologous skin.
Direct reprogramming is a breakthrough technology that can alter the fate of cells without the passage of stem cells. The team achieved direct reprogramming of mouse tail tips and embryonic fibroblasts into induced pulmonary alveolar epithelial-like cells (iPULs) using four transcription factor-coding genes (Nkx2-1, Foxa1, Foxa2, and Gata6) and three-dimensional culture. The iPULs showed lamellar body-like structures and displayed key properties of pulmonary alveolar epithelial cells. Although the potential for iPULs to morphologically differentiate into alveolar epithelial type 1 cells was limited in vitro, the intratracheal administration of iPULs in a bleomycin-induced mouse model of pulmonary fibrosis led to their integration into the alveolar surface, where they formed both alveolar epithelial type 1 and type 2-like cells. Thus, reprogrammed fibroblasts may represent a new source of pulmonary alveolar epithelial cells for regenerative medicine.